@kmakm I'm sorry to hear that. It is definitely a tough road for a lot of people, and the mental side can be very difficult to deal with. That's great you can take a couple of months off at the end of the year. Something to look forward to. Sending good vibes & love. xx
@arpie I applaud everyone that takes a concerned effort in evaluating the risks, benefits, outcomes, quality and quantity of life when deciding their treatment path. It's not easy to figure out which way to go. Mostly the Docs only give you an overview. They're doing their best with the info and treatments they can offer. One interesting part of my journey was an acquaintance who suggested immunotherapy as the way to go.. put me in touch with a cancer researcher here in Adelaide.. and the recommended treatment was in Germany.. at a cost of around 50,000 euros... !! Needless to say, this was not going to be an option. I look forward to the day when immunotherapy is offered more widely here in Australia.
For those that are interested, there is some interesting research on Asprin. The seems to be both sides, those who say it may offer benefits, and others who debunk it. When it comes to cancer treatment, there are a lot of studies.. but no cure yet.
Overall, regular
baby aspirin use reduced the risk of breast cancer 16 percent, the study says.
But the more significant finding was the risk reduction for developing
HR-positive/HER2-negative cancer, the researchers said.
Aspirin
not only reduces inflammation, but it's a mild aromatase inhibitor,"
Bernstein said. Aromatase inhibitor drugs are used to treat hormone-receptor
positive breast cancer in women past menopause, since they reduce the amount of
estrogen circulating in the blood, and the estrogen fuels the tumor.
"This is really very exciting work," said
Sushanta Banerjee, a professor of hematology and oncology at the University of
Kansas Medical Center. In his research, confined to the lab and animals, "we found that aspirin has
the capability to destroy the tumor-initiating cells that can lead to breast
cancer."
https://www.webmd.com/breast-cancer/news/20170501/low-dose-aspirin-may-lower-risk-for-common-breast-cancer-by-20-percent#1
Daily low-dose
aspirin almost halved tumor growth in breast cancer mouse models
The researchers
found that the aspirin killed the majority of breast cancer cells, with those
it failed to kill left unable to grow.
According to Dr.
Banerjee, the team found that the aspirin blocked the self-renewal activity of
the breast cancer cells. "Basically, they couldn't grow or
reproduce," he explains.
https://www.medicalnewstoday.com/articles/295304.
Taking low-dose
aspirin at least three times per week may reduce women's risk of breast cancer
by up to 20 percent, a new study suggests.
https://www.medicalnewstoday.com/articles/317248.php
Best wishes to everyone. xxx